Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Preferred Shares (2019 - 2024)

Tenax Therapeutics' Preferred Shares history spans 2 years, with the latest figure at $1.0 for Q2 2013.

  • On a quarterly basis, Preferred Shares fell 100.0% to $1.0 in Q2 2013 year-over-year; TTM through Apr 2013 was $1.0, a 100.0% decrease, with the full-year FY2013 number at $1.0, down 100.0% from a year prior.
  • Preferred Shares hit $1.0 in Q2 2013 for Tenax Therapeutics, down from $429978.0 in the prior quarter.
  • Over the last five years, Preferred Shares for TENX hit a ceiling of $3.9 million in Q1 2012 and a floor of $1.0 in Q2 2013.